Cargando…
Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome
OBJECTIVE: Asymmetric and symmetric dimethylarginines (ADMA and SDMA) are endothelial dysfunction markers. ADMA inhibits synthesis of nitric oxide. We aimed to analyze both markers in patients with coronary artery disease (CAD) who were referred for stress/rest myocardial perfusion scintigraphy (MPS...
Autores principales: | Szabo, Zsuzsanna, Bartha, Eva, Nagy, Lajos, Molnar, Tihamer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294388/ https://www.ncbi.nlm.nih.gov/pubmed/32529878 http://dx.doi.org/10.1177/0300060520920439 |
Ejemplares similares
-
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017) -
Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013) -
l-arginine, asymmetric and symmetric dimethylarginine for early outcome prediction in unselected cardiac arrest victims: a prospective cohort study
por: Csiszar, Beata, et al.
Publicado: (2021) -
Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA)
por: Arlouskaya, Yana, et al.
Publicado: (2019) -
L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
por: Pascale, Valerio, et al.
Publicado: (2013)